Pharma, FDA Got A Bum Rap On Post-Market Studies, Booz Allen Report Says
Nearly 20 percent of post-marketing studies tagged in the agency's database as open had actually been fulfilled or released, according to the backlog review.
Nearly 20 percent of post-marketing studies tagged in the agency's database as open had actually been fulfilled or released, according to the backlog review.